48 aggregated molecules. Stokrova & Sponar (1963) separated the unaggregated albumin from such an experiment and then continued heating it at 58°C. They showed that there was no further significant production of aggregated material at that temperature. It was concluded, therefore, that this experiment distinguishes between two classes of albumins, one of which aggregates more rapidly in these conditions than the other; it is not a case of a simple equilibrium being set up between the unaggregated and the aggregated forms.
Secondly, there is bisalbuminemia, those genetically determined cases where the normal plasma albumin is replaced by two albumins. One of these runs normally on electrophoresis, whilst the other runs at a distinctly different rate due to an alteration in the primary amino acid sequence. In the seven families with this condition that I have examined all the affected sera show the same thing, the ratio of the aberrant to the normal albumin being very close to 1: 1; this has been repeatedly reported by other investigators working on other families. There are two possible hypotheses to account for this. It can be postulated that in the bisalbuminwmic there is a gene change resulting in the production of an albumin with an aberrant primary amino acid sequence. At the same time this alteration produces a completely new control which ensures that the two albumins are always made in equal amounts, even from family to unrelated family. Alternatively a more simple hypothesis can be postulated that there are normally two albumins present in plasma. These albumins have the same primary amino acid sequence and the same electrophoretic mobility, but they have slightly different conformations and their ratio is maintained at 1: 1 by a control which is normally present. In bisalbuminmemia only one of these albumins is affected in its primary amino acid sequence and thus can be distinguished from the other by electrophoresis, but the normal ratio between the two albumins is maintained unaffected. There is a curious observation which suggests that this latter hypothesis might be true. When labelled thyroxine is added to normal plasma it initially tags the albumin. Sarcione & Aungst (1962) found that with a bisalbuminemic serum the whole of the labelled thyroxine went on to the aberrant albumin, not the normal one. This is not a matter of competition since the same can be observed when the albumins are separated. The second hypothesis would explain this phenomenon quite simply, thus: thyroxine tags only one of the normal albumins, not both, and in Sarcione's case of bisalbuminmmia the amino acid sequence of the thyroxine binding albumin was affected, not the other. This microheterogeneity of albumin would be beneficial to an animal, since, as suggested by the observations on thyroxine binding, alternatives in albumin conformation would provide alternatives in surface structure. This would increase the range of reactions of a primitive albumin and thus increase the number of different materials it might transport. A similar type of evolution is already recognized in y-globulin where the range of antigenic reactions of the primitive protein has been considerably increased by replacing it with a mixture of molecules with subtle alternatives in the primary amino acid sequences of their peptide chains. It may be that in albumin a similar increase in reaction and function from the original albumin has been evolved, not through having alternatives in the primary sequence of the amino acids, but through alternatives in the conformation of the molecule.
Dr Victor M Rosenoer (Department ofMedicine, Royal Free Hospital, London)
Investigation of Albumin Metabolism in Man
Investigations of protein metabolism, before the era of isotope-labelled proteins, were based largely on nitrogen balance studies. Methods are now available which measure directly the rates of albumin catabolism and synthesis. The catabolic studies are technically far simpler and, under steady state conditions, the synthesis rate of albumin can be inferred. After "311-labelled albumin is injected intravenously, the plasma, urine, and total body 1311 activity may be measured daily and the results plotted against time. If all the 131I released by the labelled protein breakdown is completely and rapidly excreted by the kidneysand this may be ensured by the administration of 200 mg potassium iodide dailythe catabolic rate can be estimated from the urinary Section ofExperimental Medicine and Therapeutics 1075 and plasma data, or, by making further assumptions regarding the albumin pools in which degradation is taking place, by kinetic analysis of the plasma activity curve alone. From these curves it is possible to obtain an estimate of the total body pool of albumin and its intravascular/ extravascular distribution.
In catabolic studies it is essential to use an undenatured preparation of labelled albumin (each batch should be checked in normal human controls). The observations must be continued over a period of one to two weeks. These studies are therefore inappropriate for determinations of short-term fluctuations in the rate of albumin degradation. The mathematical models proposed for the analysis of the catabolic data are merely hypotheses and should be critically reviewed periodically (Matthews 1957 , Jamum 1965 , Sellers et al. 1966 ; when steady states are not present, even the most elegant mathematical analysis cannot give the synthesis rate (Matthews 1961) .
The direct measurement of the rate of albumin synthesis uses the labelled precursor-product relationship. Under well-defined conditions (Reeve 1965) the specific activities of all the products from a single labelled precursor pool must be equal to that of the precursor. It is sufficient to measure the specific activity of one of these products to determine the specific activity of the precursor at the site of product synthesis. In the method proposed by McFarlane (1963) for human studies, the hepatic pool of arginine is labelled in the guanidine-C by the intravenous administration of 100-200 ,uc 14C sodium carbonate and the specific activity of this precursor pool is determined by measuring the specific activity of the newly formed urea. The total amount of albumin synthesized in time (t0-t1) is then given by the expression Total radioactivity incorporated into albumin Total amount urea x synthesized in time Total radioactivity incorporated into urea (tot,)
The activity of albumin is measured as the activity of the guanidine-C of the arginine in albumin.
In our application of this method (Jones et al. 1967) , the rate of urea synthesis is determined by measuring the plasma concentrations of 12C urea and 13C urea at timed intervals after the intravenous administration of a known amount of 13C urea. Assuming a single compartment body pool for urea, with rapid mixing, unidirectional loss of urea and no recycling of the label, these concentrations give a quantitative estimate of the 12C urea and 13C urea pool sizes, and graphical differ-entiation permits the determination at each experimental point of the rate of change of pool size, the rate of loss of urea and hence the rate of synthesis of urea. Assuming, in addition, rapid labelling, the 14C incorporated into urea is calculated from the extrapolation value to zero time of the log 14C urea concentration/time curve, estimated from three to nine hours after the injection of 14C sodium carbonate. The radioactivity incorporated into the guanidine-C of arginine in albumin is determined from the specific activities of albumin samples taken five and seven hours after the injection of 14C sodium carbonate, while the plasma volume is estimated using 1311 albumin.
This type of study lasts twelve hours in the patient, thus permitting the estimation of relatively short-term changes in synthesis rates. Unsteady states are permissible and the simultaneous study of several plasma proteins produced exclusively by the liver is possible.
The basic assumptions made are that: (1) The rates of synthesis of albumin and urea remain constant during the relatively short period of labelling. This is ensured by giving the patient a protein-free diet for fourteen hours before the study begins. (2) Both urea and albumin are synthesized within the liver cell from the same pool of labelled arginine. There is little doubt that neither albumin nor urea is synthesized extrahepatically in appreciable quantities , Bollman et al. 1924 , Craigie et al. 1965 . The evidence that they are both synthesized from the same hepatic pool of labelled arginine comes from the simultaneous study of patients in a steady state of the rate of albumin synthesis using the 14C method and the rate of albumin catabolism using the 1311-labelled PBC primary biliary cirrhosis albumin method ). The highly significant correlation between the two measured rates shown in Table 1 (r=0 958; P<0001) over a wide range of synthesis rates, gives us confidence that albumin and urea are synthesized from the same hepatic arginine pool.
The method is reproducible (Table 2) and has been used to study the effects of albumin infusions on the rate of albumin synthesis in hypoalbuminmmic subjects (Table 3 ). In this study ) the synthesis rates were measured before and four days after six daily intravenous infusions each of 50 g albumin. The infusions raised the intravascular albumin concentration and pool in all subjects, but the changes in synthesis rates were not significant. In a further study in normal dogs, an acute dilutional hypoalbuminamia was produced by infusing dextran intravenously over a two-hour period. The synthesis rates measured two weeks before and two hours after the infusions again showed no consistent relationship between the plasma concentration and synthesis rate of albumin. However, before a definitive statement that such a feedback mechanism does not exist, it will be necessary to confirm these observations considering the effect of hypervolkmia on the rate of loss of intravascular albumin into the extravascular compartment.
Summary
The scope and basic assumptions of the method used to measure directly the rate of synthesis of liver-produced plasma proteins have been described. It is a technique which may well help in unravelling the mechanisms controlling the rate of albumin synthesis in vivo.
